Synopsis
Synopsis
0
VMF
0
FDF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. Dexambutol
2. Emb Fatol
3. Emb Hefa
4. Emb-fatol
5. Emb-hefa
6. Etambutol Llorente
7. Ethambutol
8. Etibi
9. Hydrochloride, Ethambutol
10. Llorente, Etambutol
11. Miambutol
12. Myambutol
1. Ethambutol Dihydrochloride
2. Ethambutol Hcl
3. 1070-11-7
4. Myambutol
5. Dadibutol
6. Dexambutol
7. Etibi
8. Ethambutol (dihydrochloride)
9. Servambutol
10. Etapiam
11. Mycobutol
12. Tambutol
13. Ebutol
14. Cl 40881
15. Tibutol
16. (2s,2's)-2,2'-(ethane-1,2-diylbis(azanediyl))bis(butan-1-ol) Dihydrochloride
17. Jng307dj5x
18. Qe4vw5fo07
19. Ethambutol Dihydrochloride, Dl-
20. (+)-2,2'-(ethylenediimino)-di-1-butanol Dihydrochloride
21. Nsc-757022
22. Cl-40881
23. 22196-75-4
24. Dsstox_cid_25345
25. Dsstox_rid_80813
26. Dsstox_gsid_45345
27. Ethambutol 2hcl
28. Emb Dihydrochloride
29. Chebi:4878
30. (2s)-2-[2-[[(1s)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol Dihydrochloride
31. (2s)-2-[2-[[(2s)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;dihydrochloride
32. Ccris 6606
33. Ncgc00178864-03
34. Einecs 213-970-7
35. Unii-jng307dj5x
36. Unii-qe4vw5fo07
37. (+-)-ethambutol Dihydrochloride
38. Myambutol (tn)
39. Ethambutol Hydrochloride [usan:usp:jan]
40. Ethambutoli Hydrochloridum
41. Emb
42. Ncgc00016560-01
43. Cas-1070-11-7
44. (2s)-2-[(2-{[(2s)-1-hydroxybutan-2-yl]amino}ethyl)amino]butan-1-ol Dihydrochloride
45. Schembl650049
46. Spectrum1500288
47. Chembl3140361
48. Dtxsid4045345
49. Hy-b0535a
50. (+-)-2,2'-(ethylenediimino)-di-1-butanol Dihydrochloride
51. Hms1920m18
52. Kuc109574c
53. (s-(r*,r*))-2,2'-(ethylenediimino)dibutan-1-ol Dihydrochloride
54. Ksc-27-052b
55. Tox21_110494
56. 1-butanol, 2,2'-(ethylenediimino)di-, Dihydrochloride, (+)-
57. Ccg-40232
58. Mfcd21364080
59. S4004
60. Ethambutol Hydrochloride (jp17/usp)
61. Ethambutol Hydrochloride [jan]
62. 1-butanol, (1,2-ethanediyldiimino)bis-, Dihydrochloride, (r*,r*)-(+-)-
63. Akos024258527
64. Tox21_110494_1
65. Cl40881
66. Ethambutol Dihydrochloride [mi]
67. Ethambutol Hydrochloride [usan]
68. Nsc 757022
69. 1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, Dihydrochloride, (r-(r*,r*))-
70. 1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, Dihydrochloride, (s-(r*,r*))-
71. Ethambutol Hydrochloride [mart.]
72. Ethambutol Hydrochloride [vandf]
73. Ethambutol Hydrochloride [usp-rs]
74. Ethambutol Hydrochloride [who-ip]
75. Ethambutol Dihydrochloride [who-dd]
76. Ethambutol Dihydrochloride, Antimycobacterial
77. E1011
78. Sw219109-1
79. Ethambutol Hydrochloride [ep Impurity]
80. Ethambutol Hydrochloride [orange Book]
81. D00878
82. Ethambutol Hydrochloride [ep Monograph]
83. Ethambutol Hydrochloride [usp Monograph]
84. Ethambutoli Hydrochloridum [who-ip Latin]
85. A895715
86. Q27106530
87. Z1558572530
88. 2,2'-(1,2-ethanediyldiimino)bis-1-butanol Dihydrochloride
89. 2,2'-[ethane-1,2-diyldi(imino)]dibutan-1-ol Dihydrochloride
90. (s,s)-2,2'-(1,2-ethanediyldiimino)bis-1-butanol Dihydrochloride
91. (s,s)-n,n'-bis(1-hydroxy-2-butyl)ethylenediamine Dihydrochloride
92. 1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, Dihydrochloride, (r*,r*)-
93. 1-butanol, 2,2'-(ethylenediimino)di-, Dihydrochloride, (+-)-
94. Ethambutol Hydrochloride, European Pharmacopoeia (ep) Reference Standard
95. 1-butanol, 2,2'(1,2-ethanediyldiimino)bis-, Dihydrochloride, (-(r*,r*))
96. 1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, Dihydrochloride, (2r,2'r)-rel-
97. 1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, Hydrochloride (1:2), (2s,2's)-
98. Ethambutol For System Suitability, European Pharmacopoeia (ep) Reference Standard
99. Ethambutol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
100. Ethambutol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
101. 29326-86-1
Molecular Weight | 277.23 g/mol |
---|---|
Molecular Formula | C10H26Cl2N2O2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 276.1371335 g/mol |
Monoisotopic Mass | 276.1371335 g/mol |
Topological Polar Surface Area | 64.5 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 109 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Ethambutol hydrochloride |
Active Ingredient | Ethambutol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg; 400mg |
Market Status | Prescription |
Company | Lupin; Barr |
2 of 2 | |
---|---|
Drug Name | Ethambutol hydrochloride |
Active Ingredient | Ethambutol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg; 400mg |
Market Status | Prescription |
Company | Lupin; Barr |
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ethambutol Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethambutol Dihydrochloride, including repackagers and relabelers. The FDA regulates Ethambutol Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethambutol Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ethambutol Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ethambutol Dihydrochloride supplier is an individual or a company that provides Ethambutol Dihydrochloride active pharmaceutical ingredient (API) or Ethambutol Dihydrochloride finished formulations upon request. The Ethambutol Dihydrochloride suppliers may include Ethambutol Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ethambutol Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ethambutol Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ethambutol Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ethambutol Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Ethambutol Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ethambutol Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ethambutol Dihydrochloride USDMF includes data on Ethambutol Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ethambutol Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ethambutol Dihydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ethambutol Dihydrochloride Drug Master File in Japan (Ethambutol Dihydrochloride JDMF) empowers Ethambutol Dihydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ethambutol Dihydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Ethambutol Dihydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ethambutol Dihydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ethambutol Dihydrochloride Drug Master File in Korea (Ethambutol Dihydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ethambutol Dihydrochloride. The MFDS reviews the Ethambutol Dihydrochloride KDMF as part of the drug registration process and uses the information provided in the Ethambutol Dihydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ethambutol Dihydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ethambutol Dihydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ethambutol Dihydrochloride suppliers with KDMF on PharmaCompass.
A Ethambutol Dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Ethambutol Dihydrochloride Certificate of Suitability (COS). The purpose of a Ethambutol Dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ethambutol Dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ethambutol Dihydrochloride to their clients by showing that a Ethambutol Dihydrochloride CEP has been issued for it. The manufacturer submits a Ethambutol Dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ethambutol Dihydrochloride CEP holder for the record. Additionally, the data presented in the Ethambutol Dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ethambutol Dihydrochloride DMF.
A Ethambutol Dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ethambutol Dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ethambutol Dihydrochloride suppliers with CEP (COS) on PharmaCompass.
A Ethambutol Dihydrochloride written confirmation (Ethambutol Dihydrochloride WC) is an official document issued by a regulatory agency to a Ethambutol Dihydrochloride manufacturer, verifying that the manufacturing facility of a Ethambutol Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ethambutol Dihydrochloride APIs or Ethambutol Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ethambutol Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ethambutol Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ethambutol Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ethambutol Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ethambutol Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ethambutol Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ethambutol Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ethambutol Dihydrochloride suppliers with NDC on PharmaCompass.
Ethambutol Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ethambutol Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethambutol Dihydrochloride GMP manufacturer or Ethambutol Dihydrochloride GMP API supplier for your needs.
A Ethambutol Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ethambutol Dihydrochloride's compliance with Ethambutol Dihydrochloride specifications and serves as a tool for batch-level quality control.
Ethambutol Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ethambutol Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ethambutol Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethambutol Dihydrochloride EP), Ethambutol Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethambutol Dihydrochloride USP).
LOOKING FOR A SUPPLIER?